Besides its effects as a phosphaturic hormone, FGF23 also inhibits the activation of 25-(OH) vitamin D3 to 1,25-(OH)2 vitamin D3 (calcitriol), thereby potentially explaining the mild hypocalcemia and subsequent increase in circulating parathyroid hormone (PTH) following IV iron treatment. This evidence concerns the gene PTH and Hypocalcemia.